Arrivent Biopharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Arrivent Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Arrivent Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arrivent Biopharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.0M | 432k | 18.45 |
| 2025-03-31 | $1.4M | 77k | 18.49 |
| 2024-12-31 | $5.5M | 207k | 26.64 |
| 2024-09-30 | $1.7M | 73k | 23.50 |